23 Jan 2023 | 03:45 PM GMT

Masterclass: How to Move from DTx Point Solutions to Platforms?

Participants:

Abhishek Shah Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Abhishek Shah
Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Amberly Diets DirectorAVIA
Amberly Diets
DirectorAVIA
Austin Daniels Sr. Lead Product ManagerMethod
Austin Daniels
Sr. Lead Product ManagerMethod
Benjamin Alouf Chief Medical OfficerFloreo
Benjamin Alouf
Chief Medical OfficerFloreo
Cathy Zaremba Director, Product MarketingBrightInsight
Cathy Zaremba
Director, Product MarketingBrightInsight
Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC Group
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences PracticeHTEC Group
Maxime Champain Search & Evaluation lead, External InnovationBiogen
Maxime Champain
Search & Evaluation lead, External InnovationBiogen
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Sarah el Idrissi Digital Health Product ManagerAccord Healthcare
Sarah el Idrissi
Digital Health Product ManagerAccord Healthcare
Sylvain Bonnet Managing director EMEAObservia
Sylvain Bonnet
Managing director EMEAObservia
Theo Ahadome Consultant - Chief Business OfficerWellthy Therapeutics
Theo Ahadome
Consultant - Chief Business OfficerWellthy Therapeutics
Wen Dombrowski MD MBA Chief Convergence OfficerCATALAIZE
Wen Dombrowski MD MBA
Chief Convergence OfficerCATALAIZE
Zina Manji Founder/Principal, Regulatory StrategistInnopathwayz, LLC
Zina Manji
Founder/Principal, Regulatory StrategistInnopathwayz, LLC

About this Meeting

Each Masterclass is led by an expert anchor in their field as they dive into their specialty topic in front of a small intimate audience of 8-12 participants. Masterclasses also have an interactive element, allowing you a safe space to share your thoughts and experiences as well as pose questions to the expert anchors.

Why is now the right time to move from DTx point solutions to platforms? How to bring this to life?

With the accelerated growth of the DTx industry in the past few years, we have come to a saturation point. The wide range of one-point solutions available makes it very hard for patients, healthcare providers, pharma, and payers to navigate the space. Hence, the industry is realizing the need to move from one-point solutions to a platform approach that gives a holistic experience to patients and solves challenges in all the stages of the disease and treatment. 

How can we move to a platform approach? What are the benefits? How can this help in DTx deployment? Join this masterclass led by Abhishek Shah (Co-Founder and CEO at Wellthy Therapeutics), where he will walk us through: 

  • Current gaps in DTx deployment: how does a platform approach help DTx companies meet multiple stakeholder needs?
  • DTx operating system: what is it exactly, why is it important, and how to successfully build it? 
  • How can life sciences companies deploy a DTx operating system?
  • Use cases and success stories of a platform approach 
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.